ProShare Advisors’s Beam Therapeutics BEAM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $397K | Sell |
23,362
-214
| -0.9% | -$3.64K | ﹤0.01% | 1251 |
|
|
2025
Q1 | $460K | Sell |
23,576
-1,870
| -7% | -$36.5K | ﹤0.01% | 1139 |
|
|
2024
Q4 | $631K | Buy |
25,446
+6,127
| +32% | +$152K | ﹤0.01% | 1141 |
|
|
2024
Q3 | $473K | Buy |
19,319
+4,247
| +28% | +$104K | ﹤0.01% | 1168 |
|
|
2024
Q2 | $353K | Sell |
15,072
-4,439
| -23% | -$104K | ﹤0.01% | 1175 |
|
|
2024
Q1 | $645K | Buy |
19,511
+1,873
| +11% | +$61.9K | ﹤0.01% | 948 |
|
|
2023
Q4 | $480K | Buy |
17,638
+3,399
| +24% | +$92.5K | ﹤0.01% | 1062 |
|
|
2023
Q3 | $342K | Buy |
14,239
+419
| +3% | +$10.1K | ﹤0.01% | 1140 |
|
|
2023
Q2 | $441K | Buy |
13,820
+880
| +7% | +$28.1K | ﹤0.01% | 1025 |
|
|
2023
Q1 | $396K | Sell |
12,940
-1,961
| -13% | -$60K | ﹤0.01% | 1029 |
|
|
2022
Q4 | $583K | Buy |
14,901
+1,036
| +7% | +$40.5K | ﹤0.01% | 892 |
|
|
2022
Q3 | $661K | Buy |
13,865
+494
| +4% | +$23.6K | ﹤0.01% | 822 |
|
|
2022
Q2 | $516K | Sell |
13,371
-4,376
| -25% | -$169K | ﹤0.01% | 932 |
|
|
2022
Q1 | $1.02M | Sell |
17,747
-4,156
| -19% | -$238K | ﹤0.01% | 916 |
|
|
2021
Q4 | $1.75M | Buy |
21,903
+304
| +1% | +$24.2K | ﹤0.01% | 803 |
|
|
2021
Q3 | $1.88M | Sell |
21,599
-1,834
| -8% | -$160K | 0.01% | 729 |
|
|
2021
Q2 | $3.02M | Buy |
23,433
+4,726
| +25% | +$608K | 0.01% | 629 |
|
|
2021
Q1 | $1.5M | Buy |
18,707
+920
| +5% | +$73.6K | ﹤0.01% | 796 |
|
|
2020
Q4 | $1.45M | Buy |
+17,787
| New | +$1.45M | 0.01% | 730 |
|